1Qian C,Drozdzik M,Caselmann WH,et al.The potential of gene therapy in the treatment of hepatocellular carcinoma.J Hepatol,2000,32:344-351. 被引量：1
2Waldmann TA.Immunotherapy:Past,present and future.Nat Med,2003,9:269-277. 被引量：1
3Atarashi Y,Yasumura S,Nambu S,et al.A novel human tumor necrosis factor alfa mutein,F4614,inhibits in vitro and in vivo growth of murine and human hepatoma:Implication for immunotherapy of human hepatocellular carcinoma.Hepatology,1998,28:57-67. 被引量：1
4Kubo S,Nishiguchi S,Hirohashi K,et al.Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy.Br J Surg,2002,89:418-422. 被引量：1
5Lin SM,Lin CJ,Hsu CW,et al.Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors.Cancer,2004,100:376-382. 被引量：1
6Takayama T,Sekine T,Makuuchi M,et al.Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma:A randomised trial.Lancet,2000,356:802-807. 被引量：1
7O'Beirne JP,Harrison PM.The role of the immune system in the control of hepatocellular carcinoma.Eur J Gastroenterol Hepatol,2004,16:1257-1260. 被引量：1
8Anderson SC,Johnson DE,Harris MP,et al.p53 gene therapy in a rat model of hepatocellular carcinoma:Intra-arterial delivery of a recombinant adenovirus.Clin Cancer Res,1998,4:1649-1659. 被引量：1
9Schmitz V,Qian C,Ruiz J,et al.Gene therapy for liver diseases:Recent strategies for treatment of viral hepatitis and liver malignancies.Gut,2002,50:130-135. 被引量：1
10Drozdzik M,Qian C,Xie X,et al.Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma.J Hepatol,2000,32:279-286. 被引量：1
